SCHEMBL10290

SCHEMBL10290

c1cnc2cn[nH]c2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29354958 1.00
SCHEMBL17559224 1.00 IDO1 (0.46)
Benzene SCHEMBL28175560 0.98 IDO1 (0.45)
SCHEMBL28901431 0.98 IDO1 (0.45)
Fluoride SCHEMBL28159076 0.98 IDO1 (0.45)
Ammonia Solution, Strong SCHEMBL14894047 0.98 IDO1 (0.45)
SCHEMBL1434898 0.98 IDO1 (0.45)
Calcium SCHEMBL9503277 0.98 IDO1 (0.45)
Water SCHEMBL10431157 0.98 IDO1 (0.45)
Hydrochloric Acid SCHEMBL8801533 0.98 IDO1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 11428 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260146044-A1 AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF INCRELAND (CN) 2026-05-28 US claimed
EP-4213843-B1 MODIFIED IMIDAZOPYRIDINES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS MERCK SHARP & DOHME LLC (US) 2026-05-06 EP claimed
US-RE50878-E1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors CALLIDITAS THERAPEUTICS SUISSE SA (CH) 2026-05-05 US claimed
EP-4482583-B1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2026-04-01 EP claimed
EP-3597184-B1 INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES KOREA RES INST CHEMICAL TECH (KR) 2026-03-04 EP claimed
US-12559671-B2 Light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2026-02-24 US claimed
EP-4688778-A1 1H-PYRROLO[2,3-B]PYRIDIN-4-YL]-2-OXOPYRROLIDINE-3-CARBONITRILE DERIVATIVES AS TYROSINE KINASE 2 (TYK2) INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES Biogen MA Inc. (US) 2026-02-11 EP claimed
US-20260021079-A1 NOX INHIBITORS FOR USE IN THE TREATMENT OF ALPORT SYNDROME CALLIDITAS THERAPEUTICS SUISSE SA (CH) 2026-01-22 US claimed
EP-4678634-A1 ANDROGEN RECEPTOR MODULATORS AND USES THEREOF Haihe Biopharma Co., Ltd. (CN) 2026-01-14 EP claimed
EP-4654964-A1 SULFONE-1H-PYRROLE-2-CARBOXAMIDE INHIBITORS OF SARS-COV-2 NSP14 METHYLTRANSFERASE AND DERIVATIVES THEREOF The Rockefeller University (US) 2025-12-03 EP claimed
EP-0096995-A2 Pyrazolopyridine compounds ICI AMERICAS INC. (US) 1983-12-28 EP claimed
EP-0094175-A1 Pyrazolopyridine compounds ICI AMERICAS INC. (US) 1983-11-16 EP claimed
EP-0076035-A1 Pyrazolo(3,4-b)pyridine derivatives ICI AMERICAS INC. (US) 1983-04-06 EP claimed
US-4364948-A Pyrazolo[3,4-b]pyridine compounds ICI AMERICAS INC. (US) 1982-12-21 US claimed
US-4302454-A Cephalosporins SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-11-24 US claimed
US-4226863-A BACTERICIDES, ANTIBIOTICS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1980-10-07 US claimed
US-4165373-A ANTIBIOTICS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1979-08-21 US claimed
US-4156724-A N-acylamino-alpha-arylacetamido cephalosporins and antibacterial compositions and methods containing them SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1979-05-29 US claimed
US-4125611-A MICROBIOCIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1978-11-14 US claimed
US-4005075-A Penicillins and their preparation SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1977-01-25 US claimed